enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Reversible cerebral vasoconstriction syndrome - Wikipedia

    en.wikipedia.org/wiki/Reversible_cerebral...

    Reversible cerebral vasoconstriction syndrome (RCVS, sometimes called Call-Fleming syndrome) is a disease characterized by a weeks-long course of thunderclap headaches, sometimes focal neurologic signs, and occasionally seizures. [1] Symptoms are thought to arise from transient abnormalities in the blood vessels of the brain. [1]

  3. Sitagliptin/metformin - Wikipedia

    en.wikipedia.org/wiki/Sitagliptin/metformin

    In the United States, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. [5] [6]In the European Union, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in people with type 2 diabetes; in combination with a sulfonylurea as an adjunct to diet and exercise "in people ...

  4. RCVS - Wikipedia

    en.wikipedia.org/wiki/RCVS

    RCVS may refer to: Royal College of Veterinary Surgeons; Reversible cerebral vasoconstriction syndrome This page was last edited on 29 December 2019, at 21:47 (UTC). ...

  5. Sitagliptin - Wikipedia

    en.wikipedia.org/wiki/Sitagliptin

    Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes. [8] In the United Kingdom it is listed as less preferred than metformin or a sulfonylurea. [9] It is taken by mouth. [8] It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet ...

  6. The Top Foods To Limit When You're on Drugs Like Ozempic ...

    www.aol.com/top-foods-limit-youre-drugs...

    Drugs like Ozempic, Wegovy and newly-approved Zepbound have become part of the public lexicon in 2023. Though Ozempic is FDA-approved for diabetes management, Wegovy and Zepbound are sought-after ...

  7. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors ...

  8. A diabetes drug may help prevent dementia, new research shows

    www.aol.com/diabetes-drug-may-help-prevent...

    A recent study has shown that people who take SGLT-2 inhibitors for type 2 diabetes management have a 35% lower diabetes risk, overall. A diabetes drug may help prevent dementia, new research ...

  9. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

    www.aol.com/diabetes-drugs-really-safe-reliable...

    In some cases, diabetes medications that support weight loss can be game-changing tools. Here’s what to keep in mind about diabetes drugs for weight loss: GLP-1s and GIP/GLP-1s treat both ...